RecruitingNot Applicable

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

United States, Canada125 participantsStarted 2025-09-09

Plain-language summary

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 21 years or older
✓. Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance
✓. Able to stand on two bare feet unassisted
✓. Receiving automated peritoneal dialysis for the treatment of ESKD
✓. Followed on the Vantive Sharesource Remote Patient Management Platform

Exclusion criteria

✕. Undergoing or plan to undergo hemodialysis in the next 12 months
✕. Have a life expectancy of less than 12 months
✕. Are pregnant or plan to become pregnant during the next 12 months
✕. Weigh greater than 375 lbs
✕. Planned kidney transplant within the next 12 months
✕. Have an implanted neurostimulator system

What they're measuring

Sensitivity Analysis

Timeframe: 1 year

Trial details

NCT IDNCT07059962

SponsorBodyport Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Corey Centen

415-990-5415 corey@bodyport.com

View on ClinicalTrials.gov More Kidney Disease trials